Wednesday May 22, 2019 Change 1.97% Price $265.48
Chart period: 2019-02-25 - 2019-05-22
VOLUME
Sell
TREND
Sell
MV LONG
Sell

MV SHORT
Buy

PIVOT
Buy

MACD
Sell

Will ABMD stock price go up or down on Thu, 23 May 2019?

Predict

ABIOMED Forecast and Stock Analysis

Technical ABMD stock analysis for Wednesday May 22, 2019.

Hold candidate since 2019-05-22
Shorts n/a
Insider % n/a
Institutional % n/a
Beta 1.65
ROA 28.14%
Price to book USD 12.16
P/E Ratio 45.99
Next Earnings Date 2019-07-25


ABIOMED gained 1.97% in the last trading day ( Wednesday, 22nd May 2019 ), rising from $260.34 to $265.48 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During day the stock fluctuated 2.59% from a day low at $260.14 to a day high of $266.89. The price has risen in 6 of the last 10 days and is up by 2% over the past 2 weeks. Volume fell in the last day by -126 157 shares, and in total, 620 327 shares bought and sold for approximately $164.68 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Quick summary:

  • 30 day high of the ABMD stock price was $281.75 and low was $228.00.
  • 90 day high was $362.02 and low was $228.00.
  • 52 week high for the ABIOMED - $459.75 and low - $228.00.

Trend

ABIOMED lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $271.65 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -25.77% during the next 3 months and, with 90% probability hold a price between $159.14 and $201.65 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

A buy signal was issued from a pivot bottom point on Monday May 20, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. ABIOMED holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $267.71. On a fall, the stock will find some support from the short-term average at $259.63. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal.

Access today's Top 5 Golden Star Companies

A buy signal from a double bottom formation was found on Monday May 20, 2019 and based on theory for this formation the price should go up by 18.17% to $270.54 within 5 trading days since signal was issued (Tuesday May 28, 2019).

Relative Strength Index (RSI)

RSI14 is 51 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

ABIOMED finds support from accumulated volume at $264.77.

Support: $264.77 Price: $265.48 Resistance: $276.39

Risk

This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $6.75 (2.59%) between high and low. For the last week, the stock has had a daily average volatility of 3.20%.

Our recommended stoploss: $254.94 (-3.97%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 2 days ago.)

3.20 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Evaluation:

ABIOMED holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Hold/Accumulate.

Hold/Accumulate Upgraded
Previous Hold Today ABMD ranks #1731 as HOLD CANDIDATE #1731 Next Hold
ABMD $265.48 ($5.14 1.97%)
ABMD is up $5.14 today, but where's it headed in 2019?
Zacks Investment Research is releasing its prediction for ABMD based on the 1-3 month system that more than doubles the S&P 500.

This report is free today for StockInvest.us readers.

Click here – the ABMD analysis is free »

Will ABMD stock price go up or down
on Thu, 23 May 2019?

Predict

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank